Φορτώνει......
Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years
BACKGROUND: Bisphosphonate (BP) therapy has been associated with atypical femur fracture (AFF). However, the threshold of treatment duration leading to increased AFF risk is unclear. In a retrospective cohort of older women initiating BP, we compared the AFF risk associated with treatment for at lea...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | BMC Musculoskelet Disord |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BioMed Central
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7713036/ https://ncbi.nlm.nih.gov/pubmed/33272248 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12891-020-03672-w |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|